Skip to main content
Clinical Trials/NCT06853626
NCT06853626Active, not recruitingNot Applicable

Improved Management of Acute Chest Pain in Emergency Primary Care. The OUT-POC Study (One-hoUr Troponin Using a High-sensitivity Point-Of-Care Assay in Emergency Primary Care)

University of Oslo8 sites in 1 country2,500 target enrollmentStarted: June 27, 2025Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Enrollment
2,500
Locations
8
Primary Endpoint
Total number of acute myocardial infarctions at the index episode

Study Overview

Brief Summary

Acute chest pain is a prevalent medical emergency in primary emergency care settings. Triage of chest pain prior to hospital admission presents significant challenges due to the absence of sufficiently sensitive diagnostic tools. Clinical signs, symptoms, risk assessment scores, or a normal electrocardiogram (ECG) can reliably exclude acute myocardial infarction (MI). This diagnostic uncertainty has resulted in chest pain being the second most common cause for acute hospital referrals from Norwegian emergency primary care, even though chest pain is frequently non-cardiac in origin.

In acute MI events, cardiac troponins are released into the bloodstream from the damaged myocardium, where low values are used to exclude MI. Until recently, such testing has necessitated using high-sensitivity cardiac troponin (hs-cTn) assays, which have been limited to hospital laboratories. However, recent technological advancements in point-of-care (POC) testing allow access to whole-blood assays that meet high-sensitivity criteria.

In this upcoming project, the investigators will evaluate the implementation of a whole-blood POC assay (QuidelOrtho TriageTrue hs-cTnI) across six Norwegian emergency primary care clinics. The study plans to enrol 2,500 patients over a period of 1.5 years. The clinical performance of the novel strategy will be investigated, as well as its impact on healthcare utilization and hospital referrals compared to standard care. Additionally, the investigators will assess the prevalence of persistent chest pain and its effects on quality of life, alongside psychological stress and anxiety, through validated questionnaires.

This project aims to offer better and more comprehensive management of the large group of emergency primary care patients with acute chest pain, contributing to reduced hospital referrals, improved quality of life, and more sustainable use of healthcare services.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients (18+ years) with non-traumatic acute chest pain presenting in emergency primary care
  • •Troponin testing requested by the treating physician

Exclusion Criteria

  • •Acute STEMI (direct hospital referral required)
  • •Haemodynamically unstable (direct hospital referral required)
  • •Not able to provide written, informed consent (i.e., due to time restraints, language barriers, impaired cognitive function, or other reasons)

Arms & Interventions

TriageTrue hs-cTnI 0/1-hour algorithm

Other

Study participants will have a venous blood sample done for hs-cTnI testing using the QuidelOrthos TriageTrue whole-blood POC assay. The treating physician will evaluate the results using an assay-specific 0/1-hour algorithm (developed by Boeddinghaus et al., 2020).

Intervention: QuidelOrthos TriageTrue hs-cTnI whole-blood assay (Diagnostic Test)

Outcomes

Primary Outcomes

Total number of acute myocardial infarctions at the index episode

Time Frame: From baseline to 30 days

Proportion of acute myocardial infarction at baseline, to assess the predictive performance of the TriageTrue 0/1-hour algorithm (incl. safety and accuracy) at index

PROM: Health-related quality of life

Time Frame: At baseline and repeated after 90 days

Differences in health-related quality of life among chest pain participants will be assessed through self-reported EQ-5D questionnaire with five levels (EQ-5D-5L) incl. the EQ-5D visual analogue scale (EQ VAS).

Secondary Outcomes

  • PROM: Insomnia(At baseline and repeated after 90 days)
  • Healthcare utilization(From baseline to 1 year)
  • Efficiency(Baseline)
  • Total number of hospital referrals at index(Baseline)
  • Total length of stay(Baseline to 24 hours)
  • PROM: Depression(At baseline and repeated after 90 days)
  • Incremental cost-effectiveness ratio(From baseline to 1 year)
  • Healthcare costs(From baseline to 1 year)
  • Composite of acute MI and all-cause death(From baseline to 1 year)
  • PROM: Burden of chest pain(At baseline and repeated after 90 days)
  • Societal costs(From baseline to 1 year)
  • PROM: Cardiac Anxiety(At baseline and repeated after 90 days)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Tonje R. Johannessen

Principal Investigator

University of Oslo

Study Sites (8)

Loading locations...

Similar Trials